» Articles » PMID: 9716871

Carbon Dioxide Laser Microsurgery for Early Supraglottic Carcinoma

Overview
Date 1998 Aug 26
PMID 9716871
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Forty-eight untreated patients with early supraglottic carcinoma (12 patients stage I and 36 patients stage II) had primary carbon dioxide laser microsurgery between 1979 and 1994 with the intent of complete tumor removal with preservation of functionally important structures of the larynx. Ninety-six percent of the patients were treated exclusively by surgery; 4% had laser microsurgery and postoperative radiotherapy. With a median follow-up of 55 months, the 5-year local control rate with the first treatment was 100% for pT1 cases and 89% for pT2 cases. The ultimate local control rate with voice preservation, including patients successfully salvaged after a local recurrence, was 97% for pT2 carcinomas. Five (10%) patients died of tumor (TNM)-related deaths. The 3-year recurrence-free rate and 3-year overall survival rate (Kaplan-Meier) were 87% and 85%; the 5-year recurrence-free rate and 5-year overall survival rate were 83% and 76%, respectively. The results achieved with transoral laser microsurgery in early supraglottic carcinoma are comparable to those of open supraglottic laryngectomy with respect to local control and survival. The functional results are superior, since clinically relevant aspiration did not occur.

Citing Articles

Transoral Laser Microsurgery and Transoral Robotic Surgery in Aging Patients: A State-of-The-Art Review.

Lechien J Clin Interv Aging. 2024; 19:2121-2132.

PMID: 39691799 PMC: 11651065. DOI: 10.2147/CIA.S475037.


Transoral laser microsurgery for supraglottic carcinomas: results of a prospective multicenter trial (SUPRATOL).

Ambrosch P, Meuret S, Dietz A, Fazel A, Fietkau R, Tostmann R Front Oncol. 2024; 14:1440024.

PMID: 39372873 PMC: 11449847. DOI: 10.3389/fonc.2024.1440024.


An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment.

Dyckhoff G, Warta R, Herold-Mende C, Rudolph E, Plinkert P, Ramroth H Cancers (Basel). 2021; 13(3).

PMID: 33540592 PMC: 7867201. DOI: 10.3390/cancers13030568.


Best Practice in Surgical Treatment of Malignant Head and Neck Tumors.

Simon C, Nicolai P, Paderno A, Dietz A Front Oncol. 2020; 10:140.

PMID: 32117778 PMC: 7028740. DOI: 10.3389/fonc.2020.00140.


The Flex robotic system compared to transoral laser microsurgery for the resection of supraglottic carcinomas: first results and preliminary oncologic outcomes.

Hussain T, Lang S, Hasskamp P, Holtmann L, Hoing B, Mattheis S Eur Arch Otorhinolaryngol. 2020; 277(3):917-924.

PMID: 31893297 DOI: 10.1007/s00405-019-05767-0.